MDT

100.71

0%↓

A

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

RDY

13.7

-0.36%↓

HQY

82.76

-2.65%↓

MDT

100.71

0%↓

A

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

RDY

13.7

-0.36%↓

HQY

82.76

-2.65%↓

MDT

100.71

0%↓

A

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

RDY

13.7

-0.36%↓

HQY

82.76

-2.65%↓

MDT

100.71

0%↓

A

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

RDY

13.7

-0.36%↓

HQY

82.76

-2.65%↓

MDT

100.71

0%↓

A

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

RDY

13.7

-0.36%↓

HQY

82.76

-2.65%↓

Search

Prestige Consumer Healthcare

Gesloten

SectorGezondheidszorg

63.74 -2.92

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

63.15

Max

65.35

Belangrijke statistieken

By Trading Economics

Inkomsten

-5.3M

42M

Verkoop

25M

274M

K/W

Sectorgemiddelde

16.119

89.037

Winstmarge

15.399

Werknemers

600

EBITDA

7.2M

87M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+34.02% upside

Dividenden

By Dow Jones

Volgende Winsten

5 feb 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

223M

3.2B

Vorige openingsprijs

66.66

Vorige sluitingsprijs

63.74

Nieuwssentiment

By Acuity

50%

50%

2 / 352 Rangschikking in Healthcare

Prestige Consumer Healthcare Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

27 jan 2026, 23:07 UTC

Winsten

Texas Instruments Says Data Centers, Industrial Recovery Driving Growth into 1Q -- Update

27 jan 2026, 21:27 UTC

Winsten

Texas Instruments 4Q Sales Rise, Profit Falls

27 jan 2026, 23:55 UTC

Marktinformatie

Yen Weakens Slightly on Possible Technical Correction -- Market Talk

27 jan 2026, 23:47 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

27 jan 2026, 23:47 UTC

Marktinformatie

Nikkei May Decline Amid Caution Over Earnings -- Market Talk

27 jan 2026, 23:39 UTC

Marktinformatie

Gold Falls on Likely Technical Correction, Possible Profit-Taking -- Market Talk

27 jan 2026, 23:20 UTC

Winsten

SK Innovation: Asset-Impairment Losses Weighed on Earnings

27 jan 2026, 23:20 UTC

Winsten

SK Innovation: Industry Downturn, Narrower Profit Margins Weighed on Earnings

27 jan 2026, 23:19 UTC

Winsten

SK Innovation Posts Net Loss for Second Consecutive Year

27 jan 2026, 23:19 UTC

Winsten

SK Innovation 2025 Loss KRW5.406T Vs. Loss KRW2.372T >096770.SE

27 jan 2026, 23:18 UTC

Winsten

SK Innovation 2025 Oper Pft KRW448.07B Vs. Pft KRW356.07B >096770.SE

27 jan 2026, 23:18 UTC

Winsten

SK Innovation 2025 Rev KRW80.296T Vs. KRW74.243T >096770.SE

27 jan 2026, 23:11 UTC

Marktinformatie

Global Equities Roundup: Market Talk

27 jan 2026, 23:11 UTC

Marktinformatie

Alkane Resources Bull Positive on Outlook in Red-Hot Gold Market -- Market Talk

27 jan 2026, 23:07 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Freightways's Australian M&A Adds Ballast to Bull's View -- Market Talk

27 jan 2026, 22:17 UTC

Marktinformatie

U.S. Dollar Slips Following Trump Comments -- Market Talk

27 jan 2026, 22:06 UTC

Winsten

Boeing's Stepped-Up Plane Deliveries Lift Sales -- Update

27 jan 2026, 21:51 UTC

Winsten

Texas Instruments Stock Jumps on Strong Outlook -- Barrons.com

27 jan 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

27 jan 2026, 21:43 UTC

Winsten

RTX Stock Jumps After Earnings. It Has 'Great Momentum,' Says CEO. -- Barrons.com

27 jan 2026, 21:41 UTC

Winsten

GM Lost Billions on EVs, Still Beat Wall Street's Expectations -- 5th Update

27 jan 2026, 21:38 UTC

Winsten

These Stocks Are Today's Movers: UnitedHealth, Humana, Micron, Corning, CoreWeave, UPS, GM, and More -- Barrons.com

27 jan 2026, 21:32 UTC

Winsten

Ampol: Modest Profit From F&I International in 2025

27 jan 2026, 21:32 UTC

Winsten

Ampol: F&I Australia Ebit Up by High Single Digit Percent in 2025

27 jan 2026, 21:31 UTC

Winsten

Ampol: New Zealand Ebit in 2025 In Line With Prior Year

27 jan 2026, 21:31 UTC

Winsten

Ampol: Australia Convenience Retail Ebit Up Mid-Single Digit Percent in 2025

27 jan 2026, 21:30 UTC

Winsten

Ampol 4Q Lytton Refinery Production 1.56 Billion Liters

27 jan 2026, 21:29 UTC

Winsten

Ampol FY Unaudited Replacement-Cost Ebitda A$1.44 Billion

27 jan 2026, 21:29 UTC

Winsten

Ampol FY Unaudited Replacement-Cost Operating Profit A$945 Million

27 jan 2026, 21:28 UTC

Winsten

Ampol 4Q Lytton Refiner Margin US$15.14/Bbl

Peer Vergelijking

Prijswijziging

Prestige Consumer Healthcare Prognose

Koersdoel

By TipRanks

34.02% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 88 USD  34.02%

Hoogste 88 USD

Laagste 88 USD

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Prestige Consumer Healthcare - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

3 ratings

3

Buy

0

Hold

0

Sell

Sentiment

By Acuity

2 / 352 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and Debrox for ear wax removal. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; Dramamine for motion sickness relief; enemas and other laxative products under the Fleet brand name; Gaviscon for upset stomach; cough drops under the Luden's brand; Monistat for yeast infections in women; Nix for lice and parasite treatments; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; TheraTears for dry eyes; nasal saline sprays and washes under the Fess brand name; and Hydralyte for oral rehydration. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
help-icon Live chat